Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities

v3.23.1
Marketable Securities
3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
3. Marketable Securities
Marketable securities at March 31, 2023 consisted of the following (in thousands):
 
Marketable Securities
  
Amortized Cost
    
Unrealized
Gains
    
Unrealized
Losses
    
Fair Value
 
Current:
                                   
Corporate debt
   $ 2,025      $ —        $ —        $ 2,025  
Marketable securities at December 31, 2022 consisted of the following (in thousands):
 
Marketable Securities
  
Amortized Cost
    
Unrealized
Gains
    
Unrealized
Losses
    
Fair Value
 
Current:
                                   
Corporate debt
   $ 4,807      $ —        $ (32    $ 4,775  
Corporate debt includes obligations issued by investment-grade corporations. At March 31, 2023 and December 31, 2022, the Company held only investments that have maturities of less than one year.
At March 31, 2023, the Company held one debt security
that
was in an immaterial unrealized loss position for less than one year. The aggregate fair value of debt securities in an unrealized loss posi
tion at M
arch 31, 2023 was $2.0 million.
Based on the Company’s evaluation, a credit loss allowance is not required, and the Company also evaluated its security for other-than-temporary impairment and considered the decline in market value for the security to be primarily attributable to current economic and market conditions. It was not more likely than not that the Company would have been required to sell the security prior to the recovery of the amortized cost basis. Based on this analysis, these marketable securities were 
not
considered to be other-than-temporarily impaired as of March 31, 2023, and the decline in fair value below the amortized cost basis was recorded as an unrealized loss, net of tax, in other comprehensive loss in the consolidated statements of comprehensive loss.